Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00241 ALI HEALTH
RTNominal down2.610 -0.040 (-1.509%)
Others

17/05/2018 09:31

Ali Health (00241) year loss narrows to Rmb107m; no div

[ET Net News Agency, 17 May 2018] Alibaba Health Information Technology (00241) said
its loss attributable to owners of the parent for the year ended 31 March 2018 narrowed to
Rmb107 million from Rmb208 million for the previous financial year.
Basic and diluted loss per share was Rmb1.16 cents.
Revenue amounted to Rmb2,443 million, an increase of 414% from a year earlier. Gross
profit soared 248.7% year-on-year to Rmb653 million. Such strong growth in revenue and
gross profit was mainly attributable to the rapid growth in revenue from self-operated
healthcare product sales and e-commerce platform services during the year.
No final dividend will be distributed. (HL)

Back to Others

Remark: Real time quote last updated: 19/04/2024 14:28
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.